Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
for
Melanoma
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05077137
Phase 1, Recruiting
A Long-term Follow-up Study of Gaucher Disease
for
Gaucher Disease
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT03190837
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Durham NC, Roanoke VA, Charlotte NC, Charlottesville VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Ultrasound for Evaluation of Percutaneous G-tube Position
for
Gastrostomy
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 0 - 18
Code: NCT06361498
Recruiting
New
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
for
Esophageal Adenocarcinoma
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT07603375
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Durham NC, Raleigh NC, Charlotte NC, Shelby NC,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy,
Location: Durham NC, El Paso TX, Murray UT, Los Angeles CA
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07226986
Phase 1, Phase 2, Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Durham NC, North Chesterfield VA, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase 3, Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
for
Cytokine Release Syndrome
Location: Durham NC, Augusta GA, Pittsburgh PA, Boston MA,
Sponsor: CytoAgents, Inc.
Sex: All
Age: 18+
Code: NCT05905328
Phase 1, Phase 2, Recruiting
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension,
Location: Durham NC
Sponsor: Bastiaan Driehuys
Sex: All
Age: 18 - 70+
Code: NCT06104228
Phase 2, Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Durham NC, Atlanta GA, Columbus OH, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876662
Recruiting
Photon-counting CT in Chest Imaging
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT07031336
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Durham NC, Morgantown WV, Cleveland OH, Indianapolis IN,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase 2, Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Durham NC, Greenville NC, Washington D.C. DC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase 3, Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Durham NC, Raleigh NC, Charlottesville VA, Augusta GA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT02493478
Recruiting
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
for
Spinal Injuries, Spinal Deformity
Location: Durham NC, Louisville KY, New York NY, San Francisco CA
Sponsor: Columbia University
Sex: All
Age: 18 - 70+
Code: NCT02314988
Phase 2, Phase 3, Recruiting
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
for
Acute Ischemic Stroke
Location: Durham NC, Baltimore MD, Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06440707
Phase 2, Recruiting
Pain With Dementia
for
Pain, Dementia, Mild, Dementia, Moderate
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 50+
Code: NCT06854718
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
for
Glycogen Storage Disease Type Ia
Location: Durham NC, Philadelphia PA, Ann Arbor MI, Hartford CT,
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All
Age: 2+
Code: NCT06636383
Recruiting
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs